Loading...
XHKG8189
Market cap67mUSD
Dec 23, Last price  
0.28HKD
1D
1.85%
1Q
52.78%
Jan 2017
-62.84%
Name

Tianjin TEDA Biomedical Engineering Co Ltd

Chart & Performance

D1W1MN
XHKG:8189 chart
P/E
P/S
1.23
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
0.42%
Rev. gr., 5y
2.49%
Revenues
398m
-11.49%
205,031,866270,639,221327,954,880422,511,561432,000,259429,057,203511,150,674677,640,122583,111,851552,041,373501,589,528389,278,236375,906,530351,897,658358,751,734369,355,184476,384,723449,675,951397,998,097
Net income
-20m
L-24.34%
772,7463,034,418-11,377,409-8,987,6025,148,7796,142,04214,417,02624,017,31721,373,60517,787,42825,564,5125,970,713-13,752,052-177,679,819-88,810,696-50,363,356-44,784,407-26,645,819-20,159,658
CFO
-13m
L+2.60%
8,782,4601,281,10359,342,567-25,579,7435,975,653-15,921,835-36,261,42728,083,421-10,652,04419,427,774-31,805,169-7,437,03417,399,979-21,840,410-3,798,54035,987,592-6,683,968-12,821,438-13,154,710
Earnings
Mar 26, 2025

Profile

Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of biological compound fertilizer products in the People's Republic of China. The company operates in two segments, Biological Compound Fertilizers Products, and Elderly Care and Health Care Services. Its biological compound fertilizer products include active fertilizer, mixture with nitrogen, phosphorus, and potassium with various formula that are used for the facilitation of balanced growth of grains, fruits, and vegetables. The company is also involved in the provision of integrated elderly and health care; and elderly equipment leasing services, as well as consulting, advisory, and assessment services. In addition, it provides and licenses electroencephalography photography (EEG) diagnosis detection services; and conducts EEG detection and diagnosis technology services. Further, the company engages in the research, development, manufacture, and application of biomedical science and technology projects; regional soil resources conditioning and remediation business; and provision of soil environmental quality standards research services. Tianjin TEDA Biomedical Engineering Company Limited was incorporated in 2000 and is headquartered in Tianjin, the People's Republic of China.
IPO date
Jun 18, 2002
Employees
265
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
397,998
-11.49%
449,676
-5.61%
476,385
28.98%
Cost of revenue
407,857
471,906
483,035
Unusual Expense (Income)
NOPBT
(9,859)
(22,230)
(6,650)
NOPBT Margin
Operating Taxes
(1,044)
151
(55)
Tax Rate
NOPAT
(8,815)
(22,381)
(6,595)
Net income
(20,160)
-24.34%
(26,646)
-40.50%
(44,784)
-11.08%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
63,262
60,779
45,131
Long-term debt
32,169
74,446
88,155
Deferred revenue
Other long-term liabilities
(2,564)
Net debt
89,497
125,676
103,507
Cash flow
Cash from operating activities
(13,155)
(12,821)
(6,684)
CAPEX
(2,468)
(8,798)
(33,697)
Cash from investing activities
(467)
(12,931)
(8,511)
Cash from financing activities
12,729
6,169
28,102
FCF
7,930
(9,237)
22,879
Balance
Cash
5,934
9,549
29,779
Long term investments
Excess cash
5,960
Stockholders' equity
(193,897)
(178,481)
(151,835)
Invested Capital
342,034
352,515
351,053
ROIC
ROCE
EV
Common stock shares outstanding
1,894,500
1,894,500
1,894,500
Price
0.09
 
0.17
 
Market cap
168,610
 
322,065
 
EV
272,736
451,991
EBITDA
1,774
(6,840)
2,863
EV/EBITDA
153.71
157.86
Interest
5,173
6,402
5,467
Interest/NOPBT